Rankings
▼
Calendar
NVCR Q4 2018 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q4 2018 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$70M
+29.8% YoY
Gross Profit
$47M
66.9% margin
Operating Income
-$9M
-12.4% margin
Net Income
-$16M
-22.4% margin
EPS (Diluted)
$-0.17
QoQ Revenue Growth
+7.6%
Cash Flow
Operating Cash Flow
$17M
Free Cash Flow
$15M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$340M
Total Liabilities
$228M
Stockholders' Equity
$112M
Cash & Equivalents
$141M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$70M
$54M
+29.8%
Gross Profit
$47M
$38M
+22.7%
Operating Income
-$9M
-$5M
-92.3%
Net Income
-$16M
-$11M
-42.8%
Geographic Segments
UNITED STATES
$44M
63%
E M E A
$23M
32%
JAPAN
$3M
4%
← FY 2018
All Quarters
Q1 2019 →